CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 13 enrolled
Drug / intervention
Clomiphene +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02294773
NCT02294773N/ACompleted

Randomized Controlled Trial Evaluating the Timing of Intrauterine Insemination in Relation to the LH Surge

Midwest Fertility Specialists·interventional·Posted Nov 19, 2014·Updated Dec 9, 2015

In Brief

A clinical study evaluating Intrauterine Insemination, Clomiphene, and 1 other intervention for Infertility. Completed, enrolled 13 participants across 2 sites.

Detailed Summary

The aim of this study is to assess the impact of the timing of intrauterine insemination (IUI) in relation to the natural surge of luteinizing hormone (LH), as detected by home ovulation predictor kits, on pregnancy rates per treatment cycle. The study will take place at the offices of Midwest Fertility Specialists and include patients who have been independently recommended by their primary physician to undergo ovulation induction with clomiphene citrate (CC) or letrozole and IUI as therapy for infertility.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfertility
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedNov 19, 2014
Enrollment StartOct 1, 2013
Primary CompletionSep 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 11.6 years ago

Interventions

Intrauterine Inseminationprocedure

Intrauterine insemination is either performed on the day the home ovulation predictor kit first turns positive or the day after the first positive.

Clomiphenedrug

Patient is to take clomiphene citrate during cycle days 3-7.

Letrozoledrug

Patient is to take letrozole during cycle days 3-7.